Expression and significance of PTEN and VEGF in canine mammary gland tumours

Veterinary Research Communications

Volumn 32, Issue 6, 2008, Pages 463-472

  Qiu, C W ^a,b   Lin, D G ^a   Wang, J Q ^a   Li, C Y ^b   Deng, G Z ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Canine; Immuno histochemical assay; Mammary tumour; PTEN; VEGF

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VASCULOTROPIN;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOG DISEASE; FEMALE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAMMARY GLAND; NONHUMAN; PROTEIN EXPRESSION; RISK FACTOR; TUMOR VOLUME;

ANIMALS; DOG DISEASES; DOGS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; PTEN PHOSPHOHYDROLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 47749096343     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-008-9049-7     Document Type: Article

References (34)

1. Bamberger, E.S. and Perrett, C.W., 2002. Angiogenesis in epithelian ovarian cancer. Molecular Pathology, 55, 348-360
2. Brodey, R.S., Goldschmidt, M.H. and Roszl, J.R., 1983. Canine mammary gland neoplasms. Journal of the American Animal Hospital Association, 19, 61-90
3. Brunelle, M., Sartin, E.A., Wolfe, L.G., Sirois, J. and Dore, M., 2006. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines. Veterinary Pathology, 43, 656-666
4. Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S. and Anderson, M.J., 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868
5. Cantley, L.C. and Neel, B.G., 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proceedings of the National Academy of Sciences, 96, 4240-4245
6. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F. and Reed, J.C., 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-1321
7. Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y. and Greenbero, M.E., 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241
8. Di Cristofano, A. and Pandolfi, P.P., 2000. The multiple roles of PTEN in tumor suppression. Cell, 100, 387-390
9. Elston, C.W. and Ellis, I.O., 1991. Pathological prognostic factors in breast cancer. I Value of histological grade breast cancer: Experience from a large study with a long-term follow-up. Histopathology, 19, 403-410
10. Folkman, J., 1993. Tumor angiogenesis. In: Cancer Medicine, eds. Holland F, Frei E III, Bast RC Jr, Kufe DW, Morton DL, and Weichselbaum RR, pp.153-170. Lea and Febiger, Philadelphia, PA
11. Geva, E. and Jaffe, R.B., 2000. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertility and Sterility, 74, 429-437
12. Gu, J., Tamura, M. and Yamada, K.M., 1998. Tumor suppressor PTEN inhibits integrin- and growth factor- mediated mitogen-activated protein (MAP) kinase signaling pathways. The Journal of Cell Biology, 143, 1375-1383
13. Hampe, J.F. and Misdrop, W., 1974. Tumors and dysplasias of the mammary gland. Bull World Health Organ, 50, 111-133
14. Jiang, B.H., Zheng, J.Z., Aoki, M. and Vogt, P.K., 2000. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proceeding of the National Academy of Sciences, 97, 1749-1753
15. Kanae, Y., Endoh, D., Yokota, H., Taniyama, H. and Hayashi, M., 2006. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs. Journal of Veterinary Research, 67, 127-133
16. Koenig, A., Bianco, S.R., Fosmire, S., Wojcieszyn, J., and Modiano, J.F., 2002. Expression and significance of p53, rb, p21/waf-1, p16/ ink-4a, and PTEN tumor suppressor in canine melanoma. Veterinary Pathology, 39, 458-482
17. Kondo, K., Yao, M., Kobayashi, K., Ota, S., Yoshida, M., Kaneko, S., Baba, M., Sakai, N., Kishida, T., Kawakami, S., Uemura, H., Nagashima, Y., Nakatani, Y. and Hosaka, M., 2001. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines. International Journal of Cancer, 91, 219-224
18. Levine, R.A., Forest, T. and Smith, C., 2002. Tumor suppressor PTEN is mutated in canine oeteosarcoma cell lines and tumors. Veterinary Pathology, 39, 372-378
19. Maehama, T. and Dixon, J.E., 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry, 273, 13375-13378
20. Millanta, F., Lazzeri, G., Vannozzi, I., Viacava, P. and Poli, A., 2002. Correlation of vascular endothelial growth factor expression to overall survival in invasive mammary carcinomas. Veterinary Pathology, 39, 690-696
21. Misdorp, W., Else, R.W., Hellemen, A. and Lipscomb, T.P., 1999. Histological Classification of Mammary Tumors of the Dog and Cat., second series, vol 7, (Armed Forces Institute of Pathology and World Health Organization, Washington,DC)
22. Munoz, J., Lazcoz, P., Inda, M.N., Nistal, M., Pestana, A., Encio, I.J. and Castresana, J.S., 2004. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines. International Journal of Cancer, 109, 673-679
23. Mutter, G.L., Lin, M.C., Fitzgerald, J.T., Kum, J.B., Baak, J.P., Lees, J.A., Eng, C., 2000. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. Journal of the National Cancer Institue, 92, 924-930
24. Owen, L.N., 1979. A comparative study of canine and human breast cancer. Investigate Journal of Cell Pathology, 2, 257-275
25. Priester, W.A., 1979. Occurrence of mammary neoplasms in bitches in relation to breed, age, tumor type, and geographical region from which reported. Journal of Small Animal Practice, 20, 1-11
26. Salvesen, H.B., MacDonald, N., Ryan, A., Jacobs, I.J., Lynch, E.D., Akslen, L.A. and Das, S., 2001. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. International Journal of Cancer, 91, 22-26
27. Schwartzbauer, G. and Robbins, J., 2001. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. Journal of Biological Chemistry, 276, 35786-35793
28. Stambolic, V., Tsao, M.S. and Macpherson, D., 2000. High incidence of breast and endometrial neoplasia resembling human cowden syndrome in PTEN+/- mice. Cancer Research, 60, 3605-3611
29. Steck, P.A., Pershouse, M.A., Jasser, S.A. and Hadi, A., 1997. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics, 15, 356-362
30. Takahashi, Y., Kitadai, Y., Bucana, C.D., Cleary, K.R. and Ellis, L.M., 1995. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation in human colon cancer. Cancer Research, 55, 3964-3968
31. Tamura, M., Gu, J., Tran, H. and Yamada, K.M., 1999. PTEN gene and integrin signaling in cancer. Journal of the National Cancer Institue, 91, 1820-1828
32. Waite, K.A. and Eng, C., 2002. Protein PTEN: Form and function. The American Journal of Human Genetics, 70, 829-844
33. Weng, L., Brown, J. and Eng, C., 2001. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Human Molecular Genetics, 10, 237-242
34. Yuan, X.J. and Wang, Y.E., 2002. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene, 21, 319-327